More Than 13% of Northwell Health Care Providers Test Positive for Antibodies

CTI BioPharma reports six months ended 30 June 2020 financial results

Caprion-HistoGeneX partners with Viroclinics-DDL to advance infectious disease research and COVID-19 therapeutic development

First Patient Enrolled in the Phase 2 Portion of the LIO-1 Trial Evaluating the Combination of Lucitanib and Opdivo in Gynecologic Cancers

PreveCeutical to begin clinical trials of cannabinoid Sol-Gel under the COVID-19 programme

Celularity awarded USD750,000 CIRM grant to advance COVID-19 treatment in California

Johnson & Johnson to supply 100m doses of investigational COVID-19 vaccine to the US Government

Relief Therapeutics Holdings AG announces Investigational New Drug permission to test inhaled RLF-100 in patients with moderate and severe COVID-19

IMV Receives Canadian Government Funding for COVID-19 Vaccine Phase 1 Clinical Study

FDA Grants Inhaled Use IND for RLF-100 to Treat Patients with Moderate and Severe COVID-19 Aiming to Prevent Progression to Respiratory Failure

NeuroRx and Relief Therapeutics Holdings receive Investigational New Drug approval to test RLF-100

ViaCyte signs contract with W L Gore & Associates

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awards contract to SRI International

Alnylam Submits CTA Application for ALN-HSD, an Investigational RNAi Therapeutic for the Treatment of Nonalcoholic Steatohepatitis

US Food and Drug Administration Fast Track Designation for delgocitinib Cream for the Treatment of Adults with Moderate-to-Severe Chronic Hand Eczema